MoneyWorks4Me

Alembic Pharmaceuticals submits press release

13 Aug 2019 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Dorzolamide Hydrochloride Ophthalmic Solution USP, 2%. The company has also submitted its press release. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..